Literature DB >> 6254433

Viral and bacterial antibody responses in multiple sclerosis.

F Vartdal, B Vandvik, E Norrby.   

Abstract

An imprint electroimmunofixation method (IEIF) was used to characterize antibodies to eight viral antigens (measles, mumps, rubella, herpes simplex type 1, varicella-zoster, vaccinia, cytomegalovirus, adenovirus) and four bacterial antigens (beta-hemolytic streptococcus, Hemophilus influenzae type B, Escherichia coli, enterococcus) in serum and cerebrospinal fluid (CSF) of 12 patients with multiple sclerosis (MS). Twelve patients matched for age and sex sex served as controls. Evidence for intrathecal synthesis of oligoclonal antibodies to one or more antigens was found in all 12 MS patients and in 1 of the controls. In the MS group, antibodies to viruses with neurotropic properties were more frequently associated with local synthesis than antibodies to other viruses and bacteria. The types and number of locally synthesized antibodies showed no correlation with disease duration and severity. The antibodies were not associated with oligoclonal CSF IgG and appear to account for only a minor fraction of the locally synthesized CSF IgG in MS.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254433     DOI: 10.1002/ana.410080305

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

1.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls.

Authors:  S Baig; O Olsson; T Olsson; A Löve; S Jeansson; H Link
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Cytomegalovirus and multiple sclerosis risk.

Authors:  Julia Pakpoor; Jina Pakpoor; Giulio Disanto; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

4.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

Review 5.  The initiation and prevention of multiple sclerosis.

Authors:  Alberto Ascherio; Kassandra L Munger; Jan D Lünemann
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

6.  Antibodies against measles virus polypeptides in different disease conditions.

Authors:  E Norrby; C Orvell; B Vandvik; J D Cherry
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

Review 7.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01

8.  Intrathecal synthesis of virus antibodies in multiple sclerosis patients.

Authors:  T Arnadottir; M Reunanen; A Salmi
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Cryptococcal meningoencephalitis: intrathecal immunological response.

Authors:  L La Mantia; A Salmaggi; L Tajoli; D Cerrato; E Lamperti; A Nespolo; G Bussone
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849

10.  Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain.

Authors:  J P Salier; P Glynn; J M Goust; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.